Dual role of tumor necrosis factor alpha in brain injury

Esther Shohami*, Irene Ginis, John M. Hallenbeck

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

363 Scopus citations

Abstract

Brain injury (ischemia, trauma) is among the leading cause of mortality and disability in the western world. It induces increased production of tumor necrosis factor (TNFα) by brain resident cells. There is conflicting evidence on the role of this response in the injured brain, showing its potential effect in both processes of repair and of damage. This review presents data from clinical and experimental studies on the stimulation of TNFα production in brain injury and on the deleterious consequence of this acute response. Its inhibition by pharmacologic agents, neutralizing antibodies or soluble receptors has protective effects. In contrast, there are reports (from in-vitro studies or knock-out mice) on the beneficial effects of TNFα. To reconcile these apparently conflicting reports, the exact timing and extent of TNFα activation must be taken into account, as well as the presence of other mediators such as reactive oxygen species. It is suggested that the appropriate context of mediators, at any given time after brain injury may well determine whether the effect of TNFα is protective or toxic.

Original languageEnglish
Pages (from-to)119-130
Number of pages12
JournalCytokine and Growth Factor Reviews
Volume10
Issue number2
DOIs
StatePublished - Jun 1999

Keywords

  • Cerebral ischemia
  • Traumatic brain injury
  • Tumor necrosis factor-alpha

Fingerprint

Dive into the research topics of 'Dual role of tumor necrosis factor alpha in brain injury'. Together they form a unique fingerprint.

Cite this